BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2022 7:50:06 AM | Browse: 734 | Download: 2384
Publication Name World Journal of Gastroenterology
Manuscript ID 74749
Country Malaysia
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Integrative & Complementary Medicine
Manuscript Type Basic Study
Article Title Anti-tumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model
Manuscript Source Unsolicited Manuscript
All Author List Ashwaq Hamid Salem Yehya, Ayappa V Subramaniam, Muhammad Asif, Gurjeet Kaur, Amin MS Abdul Majid and Chern Ein Oon
ORCID
Author(s) ORCID Number
Ashwaq Hamid Salem Yehya http://orcid.org/0000-0001-7464-1618
Ayappa V Subramaniam http://orcid.org/0000-0002-3302-6704
Muhammad Asif http://orcid.org/0000-0001-8989-9945
Gurjeet Kaur http://orcid.org/0000-0002-6232-5703
Amin MS Abdul Majid http://orcid.org/0000-0001-7499-2258
Chern Ein Oon http://orcid.org/0000-0002-4685-6408
Funding Agency and Grant Number
Funding Agency Grant Number
NKEA Research Grant Scheme (NRGS) by the Ministry of Agriculture Malaysia 304/CIPPM/650736/k123
Corresponding Author Chern Ein Oon, PhD, Associate Professor, Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Chancellory II, Penang 11800, Malaysia. chern.oon@usm.my
Key Words Pancreatic cancer; Orthosiphon stamineus; C5EOSEW5050ESA; Gemcitabine; Complementary medicine
Core Tip The combination of C5EOSEW5050ESA at 400 mg/kg and gemcitabine synergistically reduced tumour growth compared to either drug alone by reducing Ki-67 cell proliferation marker and tumour necrosis. In addition, no signs of toxicity or damage to vital organs in single C5EOSEW5050ESA or gemcitabine and chemo-herbal combinations treated animals compared to the untreated group, indicating the safety and efficacy of the combination treatment in a short term study. Findings from this study may provide the basis for product formulation and manufacturing of botanical drugs to be used as complementary medicine for the treatment of cancer.
Publish Date 2022-08-26 07:50
Citation Yehya AHS, Subramaniam AV, Asif M, Kaur G, Abdul Majid AMS, Oon CE. Anti-tumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model. World J Gastroenterol 2022; 28(32): 4620-4634
URL https://www.wjgnet.com/1007-9327/full/v28/i32/4620.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i32.4620
Full Article (PDF) WJG-28-4620.pdf
Full Article (Word) WJG-28-4620.docx